Skip to content

The clinical study of CT-guided bipolar radiofrequency thermocoagulation of lumbar 2 sympathetic ganglion to improve diabetic peripheral neuralgia of lower limbs

The clinical study of CT-guided bipolar radiofrequency thermocoagulation of lumbar 2 sympathetic ganglion to improve diabetic peripheral neuralgia of lower limbs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071845
Enrollment
Unknown
Registered
2023-05-26
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic peripheral neuralgia of lower limbs

Interventions

M-RFTC:Ct-guided L2 sympathetic ganglion monopole double needle radiofrequency thermocoagulation was used
B-RFTC:Ct-guided L2 sympathetic ganglion bipolar radiofrequency thermocoagulation was used

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)All patients fulfilled the diagnostic criteria for diabetes according to the American Diabetes Association in 2016, and glycosylated hemoglobin (HbA1c) 4 points; (7) No treatments, such as radiofrequency and electrical stimulation, that may have affected the results of the study were given in the last month; (8) Agreed to sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Serious systemic diseases such as uncontrolled hypertension or diabetes, and cardiac dysfunction (New York Heart Association grade II–III); (2) A history of psychiatric disease; (3) Patients with infectious diseases, infection at the puncture site; (4) The investigator believes that the patient has a medical history that may confuse the study results or present other additional risks; (5) Severe coagulation dysfunction; (6) Refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
he total effective rate and significant effective rate;

Secondary

MeasureTime frame
Tramadol and pregabalin remedial dose;Adverse reactions;SF-36;Numerical Rating Scale;Peak systolic flow velocity of both lower limb arteries;Skin temperature of lower limbs;Tip perfusion index;

Countries

China

Contacts

Public ContactRi Chen

Fujian Provincial Hospital

397769916@qq.com+86 156 5993 3626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026